Blood Cancers | Tumor

Putting an Emphasis on Patient Collaboration in MPN Treatment

January 6th 2025, 2:00pm

Video

Dr. Richard “Rick" Winneker discussed advice that he would provide to patients faced with a myeloproliferative neoplasm diagnosis.

Top 4 Stories From the 2024 ASH Annual Meeting

December 24th 2024, 4:00pm

Article

CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple myeloma and other blood cancers.

Ryoncil Receives FDA Approval for Children With GVHD

December 18th 2024, 10:45pm

Article

This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease.

Pregnancy-Associated Hematological Malignancies Linked With Complications

November 29th 2024, 4:00pm

Article

Researchers have found an increased frequency of severe maternal morbidity and obstetric complications among women who received a diagnosis of a hematological malignancy during pregnancy.

Identifying Cardiovascular Disease Risk in Cancer Survivors

October 22nd 2024, 9:00pm

Article

The risk of cardiovascular disease is elevated in cancer survivors, regardless of treatment, and is influenced by cancer type and treatment-related factors.

Education on MPN Symptoms, Treatments Leads to Greater Involvement in Care

October 3rd 2024, 7:00pm

Article

An expert explained the importance of education and involvement in care for patients with myeloproliferative neoplasms.

Reblozyl May Be ‘The Standard of Care’ Now in Lower-Risk MDS, Anemia

September 24th 2024, 3:00pm

Article

An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence for patients with MDS.

In a World of Rushing, Cancer Taught Me to Slow Down

September 20th 2024, 5:00pm

Article

With my myelodysplastic syndrome and age, I find it hard to keep up; however, cancer and fatigue have taught me to live at my own pace.

Patients With Lower-Risk Myelofibrosis May Respond to Jakafi

September 18th 2024, 9:00pm

Article

Although Jakafi has been approved for patients with higher-risk myelofibrosis, those with lower-risk disease may also benefit from this treatment.

Why Transfusion Independence Matters for Patients With MDS

September 18th 2024, 7:00pm

Article

An expert explained the burden that red blood cell transfusions can place on patients with MDS.